Cannabis Global, Inc. (OTCPK: CBGL)
Health Care · Pharmaceuticals · US
$0.00
+9900.00% today · 0.0% 1Y
Cannabis Global, Inc. (OTCPK: CBGL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $829.05K and employs 3 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Cannabis Global, Inc. across four factors: quality 8/100, value 41/100. Its strongest factor is value.
CBGL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $829.05K
- Revenue (TTM)
- $1.06M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 149.68
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.29B
- Employees
- 3
- Next earnings
- —
About Cannabis Global, Inc.
Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. The company offers cannabis flower packaged, pre-rolls, and edible products to cannabis retailers and distributors; and Comply Bag, a solution for cannabis storage, transport, and tracking. It also provides managerial services in areas of the regulated hemp and cannabis industries. The company was formerly known as MCTC Holdings, Inc. and changed its name to Cannabis Global, Inc. in December 2019. Cannabis Global, Inc. was incorporated in 2005 and is headquartered in Los Angeles, California.
- ISIN
- US13767G1004
- Founded
- 2005
- Listed since
- Jun 19, 2008
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.